E1	Or:T1 Arg:T83 Arg2:T84
E2	Eq-Comparison:T2 Value:T85 Temporal-Unit:T86 Operator:T87
E3	Eq-Comparison:T3 Operator:T89 Value:T88 Value2:T90
E4	Condition:T4 Name:T91 Severity:T90
E5	And:T5 Arg:E4 Arg2:E8
E6	Eq-Comparison:T6 Operator:T92 Value:T93
E7	Eq-Comparison:T7 Temporal-Period:T94
E8	Condition:T8 Name:T95 Minimum-Count:E6 Temporality:E7
E9	Eq-Comparison:T9 Value:T96 Operator:T97 Value:T98 Unit:T99
E10	And:T10 Arg:E8 Arg2:E11
E11	Observation:T11 Name:T100 Eq-Comparison:E12
E12	Eq-Comparison:T12 Operator:T101 Value:T143
E13	Assertion:T13 Asserted:E14
E14	Study:T14 Study-Of:E86
E15	Assertion:T15 Asserted:E87
E16	Condition:T16 Name:T146
E17	Modifier:T17 Modifies:T146
E18	Or:T18 Arg:E17 Arg2:E19
E20	Condition:T20 Name:T102
E21	Or:T21 Arg:E20 Arg2:E22
E22	Condition:T22 Name:T103
E23	Condition:T23
E24	Or:T24 Arg:E23 Arg2:E25
E25	Procedure:T25 Name:T104
E26	Assertion:T26 Asserted:T27
E28	Risk:T28 Stability:T27
E29	Assertion:T29 Asserted:T105
E30	Study:T30 Stability:T105
E31	Modifier:T31 Modifies:T106
E32	Condition:T32 Name:T106
E33	Condition:T33 Name:T107
E35	Condition:T35 Name:T109
E36	Coreference:T36 Refers-To:E40
E37	Or:T37 Arg:E36 Arg2:E38
E38	Coreference:T38 Refers-To:E40
E39	Study:T39 Study-Of:E40
E40	Drug:T40
E41	Modifier:T41 Modifies:E44
E42	Or:T42 Arg:E41 Arg2:E43
E43	Negation:T43 Negates:E88
E44	Drug:T44 Temporality:E34
E45	Assertion:T45 Asserted:T112
E46	Procedure:T46 Name:T111 Stability:T112
E47	Study:T47 Study-Of:E46
E48	Modifier:T48 Modifies:T114
E49	Procedure:T49 Name:T114 Stability:T113 Temporality:E54
E50	Drug:T50 Name:T115
E51	Drug:T51 Name:T116
E52	Drug:T52 Name:T117
E53	Drug:T53 Name:T118
E54	Eq-Comparison:T54 Temporal-Period:T119 Value:T120 Temporal-Unit:T121
E55	Eq-Comparison:T55 Temporal-Period:T122
E56	Modifier:T56 Modifies:T123
E57	Condition:T57 Name:T123 Temporality:E55
E58	Drug:T58 Temporality:E60
E59	Drug:T59 Name:T125
E60	Eq-Comparison:T60 Temporal-Period:T126 Value:T127 Temporal-Unit:T128
E61	Other:T61 Is-Other:E62
E62	Study:T62
E63	Study:T63 Study-Of:E64
E64	Drug:T64 Temporality:E65
E65	Eq-Comparison:T65 Operator:T129 Value:T130 Temporal-Unit:T131
E66	Temporal-Connection:T66 Arg:E65 Arg2:E67
E67	Study:T67
E68	Eq-Comparison:T68 Temporal-Period:T132
E69	Drug:T69 Name:T133 Temporality:E68
E70	Or:T70 Arg:E69 Arg2:E72
E71	Other:T71 Is-Other:E72
E72	Procedure:T72 Name:T148
E73	Eq-Comparison:T73 Temporal-Period:T134
E74	Drug:T74 Name:T135 Temporality:E73
E75	Temporal-Connection:T75 Arg:E74 Arg2:E76
E76	Study:T76
E77	Drug:T77 Name:T137 Temporality:E90 Stability:T136
E78	Temporal-Connection:T78 Arg:E77 Arg2:E79
E79	Study:T79
E81	Eq-Comparison:T81 Temporal-Period:T138
E82	Condition:T82 Name:T139 Temporality:E81
E83	Age:T140 Eq-Comparison:E2
E84	Modifier:T141 Modifies:T95
E85	Observation:T142 Eq-Comparison:E9
E86	Procedure:T144
E87	Negation:T145 Negates:E16
E19	Modifier:T19 Modifies:T146
E27	Or:T147 Arg:E28 Arg2:E29
E34	Eq-Comparison:T34 Temporal-Period:T110
E88	Modifier:T108 Modifies:E44
E89	And:T124 Arg:E62 Arg2:E64
E90	Eq-Comparison:T149 Temporal-Period:T150
T1	Or 36 32	or
T2	Eq-Comparison 77 72	18 years of age or older
T3	Eq-Comparison 117 110	moderate to severe
T4	Condition 121 114	DLE
T5	And 126 119	with
T6	Eq-Comparison 139 132	at least one
T7	Eq-Comparison 146 139	active
T8	Condition 168 161	lesion
T9	Eq-Comparison 187 174	0.5-1.0 cm2
T10	And 197 181	with
T11	Observation 203 187	CLASI
T12	Eq-Comparison 208 191	≥ 5
T13	Assertion 229 209	Willingness
T14	Study 260 240	study
T15	Assertion 293 271	Willingness to
T16	Condition 330 308	diseased
T17	Modifier 347 325	natural
T18	Or 350 328	or
T20	Condition 409 383	Pregnancy
T21	Or 412 386	or
T22	Condition 427 401	breast feeding
T23	Condition 448 420	condition
T24	Or 451 423	or
T25	Procedure 459 431	therapy
T26	Assertion 498 470	may
T28	Risk 510 482	risk
T29	Assertion 539 511	could
T30	Study 582 554	study
T31	Modifier 598 568	Systemic
T32	Condition 618 588	Lupus Erythematosus
T33	Condition 624 593	SLE
T35	Condition 683 649	hypersensitivity
T36	Coreference 710 676	constituents
T37	Or 713 679	or
T38	Coreference 724 690	excipients
T39	Study 747 713	investigational
T40	Drug 755 721	product
T41	Modifier 786 750	prescription
T42	Or 789 753	or
T43	Negation 793 757	non
T44	Drug 819 781	medication
T45	Assertion 830 792	could
T46	Procedure 866 828	efficacy evaluations
T47	Study 879 841	study
T48	Modifier 912 872	systemic
T49	Procedure 924 884	DLE therapy
T50	Drug 960 915	systemic corticosteroids
T51	Drug 977 931	cyclosporine A
T52	Drug 992 945	azathioprine
T53	Drug 1016 968	mycophenolate mofetil
T54	Eq-Comparison 1039 989	past 1 month
T55	Eq-Comparison 1053 999	Use
T56	Modifier 1065 1011	systemic
T57	Condition 1070 1016	pain
T58	Drug 1082 1028	medications
T59	Drug 1103 1044	oxycodone
T60	Eq-Comparison 1124 1064	past 2 weeks
T61	Other 1156 1094	another
T62	Study 1180 1118	study
T63	Study 1204 1142	investigational
T64	Drug 1209 1147	drug
T65	Eq-Comparison 1225 1162	within 4 weeks
T66	Temporal-Connection 1232 1169	before
T67	Study 1243 1180	study
T68	Eq-Comparison 1254 1189	Use
T69	Drug 1278 1211	immune-suppressant
T70	Or 1281 1214	or
T71	Other 1287 1220	other
T72	Procedure 1308 1241	biological treatment
T73	Eq-Comparison 1324 1255	Starting
T74	Drug 1346 1277	antimalarial medicine
T75	Temporal-Connection 1352 1283	after
T76	Study 1375 1306	study
T77	Drug 1436 1365	antimalarial
T78	Temporal-Connection 1443 1372	before
T79	Study 1454 1383	enrollment
T81	Eq-Comparison 1504 1428	ongoing
T82	Condition 1514 1438	infection
T83	Life-Stage-And-Gender 33 29	Male
T84	Life-Stage-And-Gender 43 39	female
T85	Eq-Value 55 50	18
T86	Eq-Temporal-Unit 61 56	years
T87	Eq-Operator 77 72	or older
T88	Severity 107 100	moderate
T89	Eq-Operator 110 103	to
T90	Severity 117 110	severe
T91	Condition-Name 121 114	DLE
T92	Eq-Operator 135 128	at least
T93	Eq-Value 139 132	one
T94	Eq-Temporal-Period 146 139	active
T95	Condition-Name 168 161	lesion
T96	Eq-Value 175 166	0.5
T97	Eq-Operator 177 167	-
T98	Eq-Value 182 170	1.0
T99	Eq-Unit 187 174	cm2
T100	Observation-Name 203 187	CLASI
T101	Eq-Operator 205 189	≥
T102	Condition-Name 409 383	Pregnancy
T103	Condition-Name 427 401	breast feeding
T104	Procedure-Name 459 431	therapy
T105	Stability 549 521	interfere
T106	Condition-Name 618 588	Lupus Erythematosus
T107	Condition-Name 624 593	SLE
T109	Condition-Name 683 649	hypersensitivity
T110	Eq-Temporal-Period 766 730	Use
T112	Stability 840 802	interfere
T113	Stability 893 853	Change
T114	Procedure-Name 924 884	DLE therapy
T115	Drug-Name 960 915	systemic corticosteroids
T116	Drug-Name 977 931	cyclosporine A
T117	Drug-Name 992 945	azathioprine
T118	Drug-Name 1016 968	mycophenolate mofetil
T119	Eq-Temporal-Period 1030 981	past
T120	Eq-Value 1033 983	1
T121	Eq-Temporal-Unit 1039 989	month
T122	Eq-Temporal-Period 1053 999	Use
T123	Condition-Name 1070 1016	pain
T125	Drug-Name 1103 1044	oxycodone
T126	Eq-Temporal-Period 1115 1056	past
T127	Eq-Value 1118 1058	2
T128	Eq-Temporal-Unit 1124 1064	weeks
T129	Eq-Operator 1216 1154	within
T130	Eq-Value 1219 1156	4
T131	Eq-Temporal-Unit 1225 1162	weeks
T132	Eq-Temporal-Period 1254 1189	Use
T133	Drug-Name 1278 1211	immune-suppressant
T134	Eq-Temporal-Period 1324 1255	Starting
T135	Drug-Name 1346 1277	antimalarial medicine
T136	Stability 1415 1344	stable
T137	Drug-Name 1436 1365	antimalarial
T138	Eq-Temporal-Period 1504 1428	ongoing
T139	Condition-Name 1514 1438	infection
T140	Age 68 63	age
T141	Modifier 161 154	discoid target
T142	Observation 168 161	lesion
T143	Eq-Value 208 191	5
T144	Procedure 271 251	procedures
T145	Negation 299 277	avoid
T19	Modifier 370 348	artificial sunlight
T146	Condition-Name 330 308	diseased
T27	Stability 503 475	pose
T147	Or 528 500	or
T34	Eq-Comparison 766 730	Use
T108	Modifier 808 770	prescription
T111	Procedure-Name 866 828	efficacy evaluations
T124	And 1185 1123	with
T148	Procedure-Name 1308 1241	biological treatment
T149	Eq-Comparison 1403 1332	already
T150	Eq-Temporal-Period 1403 1332	already
A1	Assertion-Type-Value E13 hypothetical
A2	Assertion-Type-Value E15 hypothetical
A3	Assertion-Type-Value E26 hypothetical
A4	Assertion-Type-Value E29 hypothetical
A5	Assertion-Type-Value E45 hypothetical
A6	Temporal-Connection-Type-Value E66 before
A7	Temporal-Connection-Type-Value E75 after
A8	Temporal-Connection-Type-Value E78 before
A10	Life-Stage-And-Gender-Type T83 male
A11	Life-Stage-And-Gender-Type T84 female
A12	Eq-Temporal-Unit-Value T86 year
A13	Eq-Operator-Value T87 GTEQ
A14	Severity-Value T88 moderate
A15	Eq-Operator-Value T89 BETWEEN
A16	Severity-Value T90 severe
A17	Eq-Operator-Value T92 GTEQ
A18	Eq-Temporal-Period-Value T94 present
A19	Eq-Operator-Value T97 BETWEEN
A20	Eq-Operator-Value T101 GTEQ
A21	Stability-Value T105 change
A22	Eq-Temporal-Period-Value T110 present
A23	Stability-Value T112 change
A24	Stability-Value T113 change
A25	Eq-Temporal-Period-Value T119 past
A26	Eq-Temporal-Unit-Value T121 month
A27	Eq-Temporal-Period-Value T122 present
A28	Eq-Temporal-Period-Value T126 past
A29	Eq-Temporal-Unit-Value T128 week
A30	Eq-Operator-Value T129 LTEQ
A31	Eq-Temporal-Unit-Value T131 week
A32	Eq-Temporal-Period-Value T132 present
A33	Eq-Temporal-Period-Value T134 present
A34	Stability-Value T136 stable
A35	Eq-Temporal-Period-Value T138 present
A36	Stability-Value T27 change
A37	Eq-Temporal-Period-Value T150 past
R1	Caused-By Arg1:T27 Arg2:E23
R2	Caused-By Arg1:T27 Arg2:E25
R3	Abbrev-Of Arg1:E33 Arg2:E32
R4	Caused-By Arg1:E35 Arg2:E36
R5	Caused-By Arg1:E35 Arg2:E38
R6	Caused-By Arg1:T112 Arg2:E44
R7	Example-Of Arg1:E50 Arg2:E49
R8	Example-Of Arg1:E51 Arg2:E49
R9	Example-Of Arg1:E52 Arg2:E49
R10	Example-Of Arg1:E53 Arg2:E49
R11	Treatment-For Arg1:E58 Arg2:E57
R12	Example-Of Arg1:E59 Arg2:E58